# Outcomes After Planned Discontinuation of AntiSeizure Medication

> **NCT07750496** · PHASE4 · RECRUITING · sponsor: **University of Michigan** · enrollment: 40 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Discontinue antiseizure medications

## Key facts

- **NCT ID:** NCT07750496
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07750496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07750496, "Outcomes After Planned Discontinuation of AntiSeizure Medication". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07750496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*